Fabiana Alves
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fabiana Alves has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Almir Sousa Martins
Department of Physiology and Biophysics, Federal University of Minas Gerais, Belo Horizonte, Brazil
2 shared publications - Ana Ligia Barbosa Messias2 shared publications
- Bruna Carvalho Veloso
Faculdade da Saúde e Ecologia Humana
2 shared publications - Bárbara Faria Corrêa Vilela
Clínica Mangabeiras
2 shared publications - Deborah Ribeiro Nascimento2 shared publications
- Durval Batista Palhares
Universidade Federal de Mato Grosso do Sul, Brazil
2 shared publications
Latest Publications
- Open Access
- 18 February 2025
- Published by Institute of Rural Health in Journal of Pre-Clinical and Clinical Research
Gene modulation in buccal epithelial cells of patients with fibrodysplasia ossificans progressiva treated with ascorbic acid and propranolol.
Introduction and objective: Fibrodysplasia Ossificans Progressiva (FOP) is an ultra-rare genetic disease which at birth may present hallux brevis and valgus as pathognomonic signs. Post-natal heterotopic ossification (HO) progresses into disabling, inflammatory flare-ups. Mutated ACVR1 gene...
- 18 February 2025
- Published by Institute of Rural Health in Journal of Pre-Clinical and Clinical Research
Open AccessGene modulation in buccal epithelial cells of patients with fibrodysplasia ossificans progressiva treated with ascorbic acid and propranolol.
Introduction and objective: Fibrodysplasia Ossificans Progressiva (FOP) is an ultra-rare genetic disease which at birth may present hallux brevis and valgus as pathognomonic signs. Post-natal heterotopic ossification (HO) progresses into disabling, inflammatory flare-ups. Mutated ACVR1 gene...
- Open Access
- 1 October 2024
- Published by Research, Society and Development in Research, Society and Development
- Vol. 13 (10)
Decoding akathisia: The significance of dopamine and dopaminergic pathways - a case report
Background: Dopamine and dopaminergic pathways are crucial in antipsychotic treatment and the emergence of akathisia. Understanding these mechanisms is essential for effectively managing this condition. Objective: This study aims to highlight the management of akathisia in a patient with schizophrenia while underscoring the significance of dopaminergic mechanisms in treatment. Methods: Following the CARE (CAse REports) guidelines, this study presents a case report that serves as a practical representation of clinical scenarios, contextualizing theoretical concepts through real-world examples, enhancing the understanding of rare conditions and unique treatment responses. Case Report and Discussion: A 59-year-old female patient diagnosed with schizophrenia developed severe akathisia after starting risperidone. She exhibited intense restlessness and emotional distress, requiring adjustments to her treatment regimen, including the addition of propranolol, clonazepam, and phenytoin. This case illustrates the intricate relationship between dopamine dysregulation and akathisia, emphasizing the necessity for personalized treatment strategies tailored to the patient's needs. It highlights the importance of close monitoring and flexible management in addressing adverse effects associated with antipsychotic medications. Furthermore, fostering a supportive therapeutic relationship with the mental health team and incorporating familial support significantly contributed to the patient's overall treatment success. Conclusion: Understanding dopaminergic pathways is vital for managing akathisia and schizophrenia. This study advocates for a holistic treatment approach that integrates clinical insights with psychosocial factors to improve the patient's quality of life and treatment adherence.
- 1 October 2024
- Published by Research, Society and Development in Research, Society and Development
- Vol. 13 (10)
Open AccessDecoding akathisia: The significance of dopamine and dopaminergic pathways - a case report
Background: Dopamine and dopaminergic pathways are crucial in antipsychotic treatment and the emergence of akathisia. Understanding these mechanisms is essential for effectively managing this condition. Objective: This study aims to highlight the management of akathisia in a patient with schizophrenia while underscoring the significance of dopaminergic mechanisms in treatment. Methods: Following the CARE (CAse REports) guidelines, this study presents a case report that serves as a practical representation of clinical scenarios, contextualizing theoretical concepts through real-world examples, enhancing the understanding of rare conditions and unique treatment responses. Case Report and Discussion: A 59-year-old female patient diagnosed with schizophrenia developed severe akathisia after starting risperidone. She exhibited intense restlessness and emotional distress, requiring adjustments to her treatment regimen, including the addition of propranolol, clonazepam, and phenytoin. This case illustrates the intricate relationship between dopamine dysregulation and akathisia, emphasizing the necessity for personalized treatment strategies tailored to the patient's needs. It highlights the importance of close monitoring and flexible management in addressing adverse effects associated with antipsychotic medications. Furthermore, fostering a supportive therapeutic relationship with the mental health team and incorporating familial support significantly contributed to the patient's overall treatment success. Conclusion: Understanding dopaminergic pathways is vital for managing akathisia and schizophrenia. This study advocates for a holistic treatment approach that integrates clinical insights with psychosocial factors to improve the patient's quality of life and treatment adherence.
- Open Access
- 1 October 2024
- Published by Research, Society and Development in Research, Society and Development
- Vol. 13 (10)
In-depth analysis of antipsychotic-induced akathisia: An integrative literature review
Background: Antipsychotic-induced akathisia poses a significant challenge in clinical practice due to its frequent oversight in diagnosis and associated severe consequences such as suicidal behavior and compromised treatment adherence. Understanding the underlying mechanisms and implementing effective management strategies are imperative in addressing this clinical concern. Objective: provide an updated understanding of the correlation between antipsychotics and akathisia, discussing its pathophysiology, diagnosis, assessment, and current as well as prospective treatment options. Methods: An integrative literature review was conducted utilizing Pubmed and Virtual Health Library databases, supplemented by additional resources to broaden the study's scope. Results and Discussion: Among the 204 studies analyzed, 17 met the criteria for inclusion in the review, complemented by 7 articles focusing on assessment scales. The study explores the impact of neuroleptic medications on akathisia's pathophysiology, diagnostic approaches, symptomatology, assessment tools, and management strategies. Conclusion: Robust research endeavors are crucial to consolidate evidence, identify gaps, and offer a holistic perspective on akathisia. The profound comprehension of the condition reveals paths to enhance patients' quality of life.
- 1 October 2024
- Published by Research, Society and Development in Research, Society and Development
- Vol. 13 (10)
Open AccessIn-depth analysis of antipsychotic-induced akathisia: An integrative literature review
Background: Antipsychotic-induced akathisia poses a significant challenge in clinical practice due to its frequent oversight in diagnosis and associated severe consequences such as suicidal behavior and compromised treatment adherence. Understanding the underlying mechanisms and implementing effective management strategies are imperative in addressing this clinical concern. Objective: provide an updated understanding of the correlation between antipsychotics and akathisia, discussing its pathophysiology, diagnosis, assessment, and current as well as prospective treatment options. Methods: An integrative literature review was conducted utilizing Pubmed and Virtual Health Library databases, supplemented by additional resources to broaden the study's scope. Results and Discussion: Among the 204 studies analyzed, 17 met the criteria for inclusion in the review, complemented by 7 articles focusing on assessment scales. The study explores the impact of neuroleptic medications on akathisia's pathophysiology, diagnostic approaches, symptomatology, assessment tools, and management strategies. Conclusion: Robust research endeavors are crucial to consolidate evidence, identify gaps, and offer a holistic perspective on akathisia. The profound comprehension of the condition reveals paths to enhance patients' quality of life.
- Open Access
- 4 June 2024
- Published by Institute of Rural Health in Journal of Pre-Clinical and Clinical Research
Buccal epithelial cells as non-invasive biological material for fibrodysplasia ossificans progressiva gene expression studies
Introduction and objective: The congenital disease Fibrodysplasia Ossificans Progressiva (FOP) is extremely rare, characterized by irreversible and intractable skeletal malformations, with devastating heterotopic ossifications. FOP is associated with a change in the amino acid of the ACVR1...
- 4 June 2024
- Published by Institute of Rural Health in Journal of Pre-Clinical and Clinical Research
Open AccessBuccal epithelial cells as non-invasive biological material for fibrodysplasia ossificans progressiva gene expression studies
Introduction and objective: The congenital disease Fibrodysplasia Ossificans Progressiva (FOP) is extremely rare, characterized by irreversible and intractable skeletal malformations, with devastating heterotopic ossifications. FOP is associated with a change in the amino acid of the ACVR1...